The once-popular drug, which was developed by GlaxoSmithKline, was pulled amid fears it contained a cancer-causing chemical.
MARKET REPORT: Zantac deadline ruling a reprieve for drug giants
Firenewsfeed delivers up-to-date news, stories, and events as they happen when they happen.
